CVS vs SLQT
CVS: A leading health solutions company integrating retail pharmacy, pharmacy benefit management, and insurance services to manage health costs and improve access to care. SLQT: A technology-driven insurance marketplace for seniors that is diversifying into integrated healthcare services like pharmacy and chronic care management.
Side-by-side fundamentals
| Metric | CVS | SLQT | Edge |
|---|---|---|---|
| Price as of 2026-10-20 close | $94.75 | $0.3039 | |
| Market cap | $121.2B | $54M | |
| P/E as of 2026-10-20 | 25.00 | n/a | |
| Net margin | +0.4% | +3.8% | SLQT higher |
| Operating margin | +1.2% | +4.6% | SLQT higher |
| ROE | +2.4% | +17.7% | SLQT higher |
| ROA | +0.7% | +4.8% | SLQT higher |
| Debt / equity | 0.77 | 1.05 | CVS lower |
| Revenue growth (YoY) | +7.8% | +6.0% | CVS higher |
| Revenue CAGR (3y) SEC XBRL | +7.6% | +17.3% | SLQT higher |
| Dividend yield as of 2026-09-03 | +3.0% | n/a | |
| Dividend streak (yrs) SEC XBRL | 19 | 3 | CVS higher |
| Beta as of 2026-09-03 | 0.28 | 1.55 | |
| 1-year return as of 2026-10-20 close | +14.9% | -84.7% | CVS higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.